We are live on ! Find out more
PM

Ponoi Management Portfolio holdings

AUM $73.2M
1-Year Est. Return 23.44%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
-23.44%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$108M
AUM Growth
-$4.17M
Cap. Flow
-$7.11M
Cap. Flow %
-6.55%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
NRIX icon
Nurix Therapeutics
NRIX
+$7.11M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAPT
1
DELISTED
RAPT Therapeutics
RAPT
$58.7M 54.16%
199,927
– –
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$23M 21.21%
1,298,908
– –
RVMD icon
3
Revolution Medicines
RVMD
$47.4B
$17.2M 15.9%
685,011
– –
NRIX icon
4
Nurix Therapeutics
NRIX
$2.79B
$9.47M 8.73%
327,122
-234,451
-42% -$7.11M

Similar funds

RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
WM
Westpark Management Plano, Texas $75.3M AUM 22.07% 1-Year Est. Return
NVPX
Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return
FFMBT
First Farmers & Merchants Bank Trust Columbia, Tennessee $75.4M AUM 6.56% 1-Year Est. Return
SMC
S. Muoio & Co New York $75.7M AUM 42.51% 1-Year Est. Return
CCM
Composite Capital Management Hong Kong $70.1M AUM 79.53% 1-Year Est. Return
RA
Ratos AB Stockholm, Sweden $76.4M AUM
GI
Gavea Investimentos Rj, Brazil $77.6M AUM 64.56% 1-Year Est. Return

Ponoi Management's Q4 2021 Portfolio in Review

As of Q4 2021, Ponoi Management held 4 positions worth $108M, down 3.7% from $113M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Ponoi Management withdrew a net $7.11M in Q4 2021, reducing 1 holding. Its largest reduction was Nurix Therapeutics, cutting an estimated $7.11M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Ponoi Management's biggest Q4 2021 reduction was Nurix Therapeutics, cutting an estimated $7.11M.
  • Ponoi Management's ten largest holdings make up 100% of its $108M portfolio in Q4 2021.
  • Ponoi Management opened 0 new positions and closed 0 in Q4 2021.
  • Ponoi Management's portfolio value fell 3.7% quarter-over-quarter to $108M.

Based on Ponoi Management's 13F filing for Q4 2021, filed 11 Feb 2022.